Company intelligence / Profile preview

Cmark Capital

Shenzhen, Guangdong, China

Ownership: Private
Development stage: Other

Overview

C-Mark Capital is a venture capital firm headquartered in Shenzhen, China, that focuses on investments in the healthcare, life sciences, and technology sectors. The firm primarily targets early and growth-stage companies involved in innovative drug development, medical devices, and healthcare services. By providing both capital and strategic resources, C-Mark Capital supports the growth of high-potential startups in the Chinese and global markets. Its portfolio includes several prominent biotechnology companies, reflecting its commitment to advancing medical innovation.

Industry: Investors

Beyond the preview

Go deeper on Cmark Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cmark Capital.

Explore the full profile